Curcumin,a potent anti-tumor reagent,is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation

被引:0
|
作者
Hong-li LIU~2
机构
基金
中国国家自然科学基金;
关键词
curcumin; histone deacetylase; acetylated histone H4; Raji;
D O I
暂无
中图分类号
R733.1 [网状内皮系统肿瘤];
学科分类号
100214 ;
摘要
Aim:To investigate curcumin(diferuloylmethane)induced apoptosis and its mo-lecular mechanism of action in B-NHL cell line Raji cells.Methods:Raji cells werecultured in RPMI-1640 medium and treated with curcumin in different concentra-tions.3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium(MTT)assay wasused to detect growth inhibition and Hoechst 33258 staining was used to detectapoptosis.Immunocytochemistry and Western blot were used to detect the ex-pressions of histone deacetylase 1,3,and 8(HDAC 1,HDAC3,and HDACS)andacetylated histone H4(Ac-histone H4)protein.Results:Curcumin inhibited theproliferation of B-NHL cell line Raji cells with a 36-h IC50value of 24.1±2.0μmol/L.Hoechst 33258 staining showed that curcumin could induce Raji cell apoptosis.The expression levels of HDAC1,HDAC3,and HDAC8 proteins were downregulat-ed following curcumin treatment in Raji cells,whereas Ac-histone H4 protein expres-sion was upregulated after treatment with curcumin.Conclusion:Curcumin,as anew member of the histone deacetylase inhibitors,can inhibit the expression ofclass I HDACs(HDAC1,HDAC3,and HDAC8),and can increase the expressionof Ac-histone H4 in Raji cells.Curcumin plays an important role in regulatingB-NHL cell line Raji cell proliferation and apoptosis.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 50 条
  • [1] Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation
    Liu, HL
    Chen, Y
    Cui, CH
    Zhou, JF
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (05) : 603 - 609
  • [2] Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation
    Hong-li Liu
    Yan Chen
    Guo-hui Cui
    Jian-feng Zhou
    Acta Pharmacologica Sinica, 2005, 26 : 603 - 609
  • [3] Histone Deacetylase Inhibitor Trichostatin A Enhances Anti-tumor Effects of Docetaxel or Erlotinib in A549 Cell Line
    Zhang, Qun-Cheng
    Jiang, Shu-Juan
    Zhang, Song
    Ma, Xiao-Bin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (07) : 3471 - 3476
  • [4] HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A ENHANCES ANTI-TUMOR EFFECT OF DOCETAXEL OR ERLOTINIB IN A549 CELL LINE
    Jiang, S.
    RESPIROLOGY, 2011, 16 : 164 - 164
  • [5] The Histone Deacetylase Inhibitor OBP-801 Exhibits Potent Anti-Tumor Activity Against Neuroblastoma
    Kaneda, Daisuke
    Kikuchi, Ken
    Yagyu, Shigeki
    Iehara, Tomoko
    Sakai, Toshiyuki
    Hosoi, Hajime
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S40 - S41
  • [6] Anti-tumor activity of a novel histone deacetylase inhibitor, OSU-HDAC42, in oral squamous cell carcinoma
    Weng, Jing-Ru
    Tasi, Chen-Hsun
    Pan, Shiow-Lin
    Guh, Jih-Hwa
    Chiu, Chang-Fang
    Tsai, Ming-Hsui
    CANCER RESEARCH, 2009, 69
  • [7] Entinostat, a Novel Histone Deacetylase (HiDAC) Inhibitor Is Active in B-Cell Lymphoma and Enhances the Anti-Tumor Activity of Rituximab, Chemotherapy Agents and Proteasome Inhibitors
    Frys, Sarah
    Barth, Matthew J.
    Mavis, Cory
    Gu, Juan
    Gibbs, John
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Francisco
    BLOOD, 2012, 120 (21)
  • [8] Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line
    Chen, Weiwei
    Wei, Feng
    Xu, Jing
    Wang, Yucai
    Chen, Longbang
    Wang, Jinghua
    Guan, Xiaoxiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (06) : 985 - 991
  • [9] The Anti-Tumor Histone Deacetylase Inhibitor SAHA and the Natural Flavonoid Curcumin Exhibit Synergistic Neuroprotection against Amyloid-Beta Toxicity
    Meng, Jia
    Li, Yan
    Camarillo, Cynthia
    Yao, Yue
    Zhang, Yina
    Xu, Chun
    Jiang, Lihong
    PLOS ONE, 2014, 9 (01):
  • [10] Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor
    Kim, Dong Hoon
    Lee, Jiyong
    Kim, Kyung Noo
    Kim, Hye Jin
    Jeung, Hei Cheul
    Chung, Hyun Cheol
    Kwon, Ho Jeong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 356 (01) : 233 - 238